-+ 0.00%
-+ 0.00%
-+ 0.00%

*Denali Therapeutics: FDA Awarded PRV Following Accelerated Approval of Enzyme Replacement Therapy AVLAYAH for Treatment of Hunter Syndrome in March >DNLI

Dow Jones·06/18/2026 12:02:00

Please log in to view news